A
1.17
0.00 (0.00%)
| Previous Close | 1.17 |
| Open | 1.09 |
| Volume | 238,707 |
| Avg. Volume (3M) | 686,335 |
| Market Cap | 58,285,184 |
| Price / Sales | 0.800 |
| Price / Book | 6.45 |
| 52 Weeks Range | |
| Earnings Date | 12 May 2025 - 16 May 2025 |
| Profit Margin | -59.44% |
| Operating Margin (TTM) | -79.73% |
| Diluted EPS (TTM) | -0.960 |
| Quarterly Revenue Growth (YOY) | -9.30% |
| Total Debt/Equity (MRQ) | 1,107.91% |
| Current Ratio (MRQ) | 0.610 |
| Operating Cash Flow (TTM) | -30.49 M |
| Levered Free Cash Flow (TTM) | -15.14 M |
| Return on Assets (TTM) | -17.49% |
| Return on Equity (TTM) | -354.27% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Akoya BioSciences, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.7 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | 0.0 |
| Relative Valuation | NA |
| Financial Health | -5.0 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -1.20 |
Select this tab to load the latest available analysis.
|
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler® (formerly CODEX) and PhenoImager® (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 72.58% |
| % Held by Institutions | 69.80% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Peddock Capital Advisors, Llc | 30 Sep 2024 | 234,720 |
| Osterweis Capital Management Inc | 30 Sep 2024 | 126,131 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |